Testing effectiveness (Phase 2)UnknownNCT03951337What this trial is testing64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)Who this might be right forRectal Cancer Institut Cancerologie de l'Ouest 70
Testing effectiveness (Phase 2)Looking for participantsNCT06721286What this trial is testingToripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)UnknownNCT05076851What this trial is testingNeoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate CancerWho this might be right forNeoadjuvant Therapy \High Risk Prostate Cancer Hongqian Guo 2
Early research (Phase 1)UnknownNCT05185531What this trial is testingNeoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)Study completedNCT02324595What this trial is testingMinimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility StudyWho this might be right forStage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer Catholic University of the Sacred Heart 30
Testing effectiveness (Phase 2)UnknownNCT04180995What this trial is testingToripalimab in Combination With Axitinib in Patients With Localized Mucosal MelanomaWho this might be right forMucosal Melanoma Peking University Cancer Hospital & Institute 30
Not applicableUnknownNCT05964595What this trial is testingTemporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant TherapyWho this might be right forHead and Neck Squamous Cell CarcinomaMagnetic Resonance ImagingNeoadjuvant Therapy Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 136
Large-scale testing (Phase 3)Active Not RecruitingNCT02568839What this trial is testingNeoadjuvant Response-guided Treatment of HER2 Positive Breast CancerWho this might be right forEarly-Stage Breast CarcinomaHER-2 Positive Breast Cancer Thomas Hatschek 202
Testing effectiveness (Phase 2)UnknownNCT03487939What this trial is testingNeoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal CancerWho this might be right forColorectal NeoplasmsDrug Therapy China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT04996797What this trial is testingSafety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)Who this might be right forUlcerative Colitis Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618910What this trial is testingRetlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Tang-Du Hospital 33
Not applicableUnknownNCT04489368What this trial is testingResponse Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine LearningWho this might be right forEsophageal Neoplasm Dr Kundan Singh Chufal 150
Not applicableActive Not RecruitingNCT05985551What this trial is testingDelayed SLND for Patients With Breast Cancer Undergoing Primary Systemic TreatmentWho this might be right forBreast CancerChemotherapy EffectSentinel Lymph Node Uppsala University 114
Not applicableLooking for participantsNCT07546695What this trial is testingRole of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC StudyWho this might be right forBreast Cancer University Hospital, Basel, Switzerland 600
Not applicableStudy completedNCT06630481What this trial is testingLong-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP GradeWho this might be right forPancreatic CancerNeoadjuvant TherapyPathological Complete Response Seoul National University Hospital 462
Testing effectiveness (Phase 2)UnknownNCT05556200What this trial is testingA Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILsWho this might be right forBreast CancerTriple-Negative Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Testing effectiveness (Phase 2)UnknownNCT05833971What this trial is testingCadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell CarcinomaWho this might be right forResectable Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy Guangzhou Institute of Respiratory Disease 43
Not applicableStudy completedNCT01293032What this trial is testingHormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancerWho this might be right forDuctal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more Virginia Commonwealth University 59
Testing effectiveness (Phase 2)WithdrawnNCT04418895What this trial is testingNeoadjuvant Therapy for Localized Rectal AdenocarcinomaWho this might be right forRectal Adenocarcinoma UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06790212What this trial is testingNeoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon CancerWho this might be right forColon Cancer Sun Yat-sen University 168